-
EP3760616
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3760616
| EP3760616 - 4-METHYLDIHYDROPYRIMIDINONE COMPOUND AND MEDICINAL USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 04.12.2020 Database last updated on 09.07.2024 | |
| Former | The international publication has been made Status updated on 07.09.2019 | Most recent event Tooltip | 23.02.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Japan Tobacco Inc. 1-1, Toranomon 4-chome Minato-ku Tokyo 105-6927 / JP | [2021/01] | Inventor(s) | 01 /
SAKAI, Takayuki c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc., 1-1, Murasaki-cho Takatsuki-shi, Osaka 569-1125 / JP | 02 /
IKENOGAMI, Taku c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc., 1-1, Murasaki-cho Takatsuki-shi, Osaka 569-1125 / JP | [2021/01] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2021/01] | Application number, filing date | 19759983.0 | 27.02.2019 | [2021/01] | WO2019JP07433 | Priority number, date | JP20180035597 | 28.02.2018 Original published format: JP 2018035597 | [2021/01] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019167981 | Date: | 06.09.2019 | Language: | JA | [2019/36] | Type: | A1 Application with search report | No.: | EP3760616 | Date: | 06.01.2021 | Language: | EN | [2021/01] | Search report(s) | International search report - published on: | JP | 06.09.2019 | (Supplementary) European search report - dispatched on: | EP | 30.09.2021 | Classification | IPC: | C07D239/22, A61K31/513, A61P3/00, A61P27/04, A61P35/00, A61P37/02, A61P37/08 | [2021/01] | CPC: |
A61P37/02 (EP,IL,US);
C07D233/70 (IL,US);
C07D239/22 (EP,KR);
A61K31/513 (KR);
A61P1/02 (KR);
A61P27/02 (KR);
A61P3/00 (KR);
A61P35/00 (KR);
A61P37/00 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/01] | Extension states | BA | 28.09.2020 | ME | 28.09.2020 | Title | German: | 4-METHYLDIHYDROPYRIMIDINONVERBINDUNG UND MEDIZINISCHE VERWENDUNG DAVON | [2021/01] | English: | 4-METHYLDIHYDROPYRIMIDINONE COMPOUND AND MEDICINAL USE THEREOF | [2021/01] | French: | COMPOSÉ DE 4-MÉTHYLDIHYDROPYRIMIDINONE ET SON UTILISATION MÉDICINALE | [2021/01] | Entry into regional phase | 11.09.2020 | Translation filed | 28.09.2020 | National basic fee paid | 28.09.2020 | Search fee paid | 28.09.2020 | Designation fee(s) paid | 28.09.2020 | Examination fee paid | Examination procedure | 28.09.2020 | Examination requested [2021/01] | 27.04.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 22.02.2021 | Renewal fee patent year 03 | 21.02.2022 | Renewal fee patent year 04 | 22.02.2023 | Renewal fee patent year 05 | 22.02.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]EP3231793 (JAPAN TOBACCO INC [JP]); | International search | [A]JP2015524449 ; | [X]WO2016093342 (JAPAN TOBACCO INC [JP]) |